Loading Events

« All Events

Thyroid Health and Eating Disorders: A Critical Connection for Dietitians

August 20 @ 10:00 am - 11:00 am PDT

Eating disorders (EDs) are complex psychiatric conditions with profound physiological consequences, notably impacting thyroid function. This presentation will delve into the intricate relationship between malnutrition, adaptive metabolic changes, and thyroid health in ED patients, with a particular focus on Euthyroid Sick Syndrome (ESS).

We will explore the mechanisms underlying ESS, its characteristic laboratory findings, and its clinical presentation, emphasizing how it mimics primary hypothyroidism. During nutritional rehabilitation, the body transitions into a hypermetabolic state, where the normalization and potential ‘overshoot’ of thyroid hormone levels, particularly T3, significantly contribute to increased energy expenditure, posing substantial challenges for weight restoration. A critical discussion will highlight the significant risks associated with inappropriate thyroid hormone replacement in this population, including the exacerbation of cardiac complications and the reinforcement of disordered eating behaviors.

Furthermore, we will briefly address the symptomatic overlap between EDs and conditions like POTS, EDS, and MCAS, underscoring the importance of vigilant eating disorder screening. The presentation will empower eating disorder specialized dietitians with essential knowledge for comprehensive patient assessment, prioritizing nutritional rehabilitation as the cornerstone of ESS and hypermetabolism management, and fostering interdisciplinary collaboration to optimize patient outcomes.

Learning Objectives:

Following this presentation, participants will be able to:

  1. Differentiate Euthyroid Sick Syndrome (ESS) from Primary Hypothyroidism: Participants will be able to distinguish between Euthyroid Sick Syndrome (ESS) and primary hypothyroidism in eating disorder patients based on key laboratory findings and clinical context, recognizing ESS as an adaptive metabolic response to malnutrition.
  2. Identify Risks of Inappropriate Thyroid Hormone Replacement: Participants will be able to articulate the significant medical and behavioral risks associated with the inappropriate use of exogenous thyroid hormones in eating disorder patients, particularly those with ESS.
  3. Prioritize Nutritional Rehabilitation for ESS and Hypermetabolism Management: Participants will be able to explain why nutritional rehabilitation is the cornerstone of ESS and hypermetabolism management in eating disorders and describe its role in normalizing metabolic and thyroid function.

Anne Marie O’Melia, MS, MD, FAAP, CEDS-C (she/her) Bio:

As Chief Clinical and Quality Officer, Dr. O’Melia is responsible for the oversight of clinical excellence delivered by ERC Pathlight’s therapists, dietitians and nurses nationwide. Dr. O’Melia is a board certified pediatrician and a child and adolescent psychiatrist. She has more than 30 years of experience serving children and adults with mental health problems especially those with comorbid exacerbating medical conditions.
Prior to attending medical school, she earned her Master’s Degree in Counseling Psychology from the University of Kentucky (UK) and practiced as a psychologist in rural community mental health settings. She earned her Medical Degree with Distinction from the UK College of Medicine and completed residency training at the University of Utah Triple Board Program.
She went on to serve on faculty in the Departments of Pediatrics and Psychiatry at the University of Utah and then at the University of Cincinnati before joining the medical staff at ERCPL in 2014.
Dr. O’Melia has co-authored multiple articles and book chapters on eating disorders and served as a co-investigator for various clinical trials related to psychopharmacology in the treatment of eating disorders and mood disorders.
Anne took on the role of ERCPL’s Chief Medical Officer in 2018 and then assumed the additional responsibility of Chief Clinical Officer in 2019. Last year, she once again refined her role to now include responsibilities as our Chief Clinical and Quality Officer.

Details

Date:
August 20
Time:
10:00 am - 11:00 am PDT
Event Category: